These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

478 related items for PubMed ID: 28397855

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Identification of New Shikonin Derivatives as Antitumor Agents Targeting STAT3 SH2 Domain.
    Qiu HY, Zhu X, Luo YL, Lin HY, Tang CY, Qi JL, Pang YJ, Yang RW, Lu GH, Wang XM, Yang YH.
    Sci Rep; 2017 Jun 06; 7(1):2863. PubMed ID: 28588262
    [Abstract] [Full Text] [Related]

  • 4. The Effect of a Newly Synthesized Ferrocene Derivative against MCF-7 Breast Cancer Cells and Spheroid Stem Cells through ROS Production and Inhibition of JAK2/STAT3 Signaling Pathway.
    Nourbakhsh M, Farzaneh S, Taghikhani A, Zarghi A, Noori S.
    Anticancer Agents Med Chem; 2020 Jun 06; 20(7):875-886. PubMed ID: 31893999
    [Abstract] [Full Text] [Related]

  • 5. A novel curcumin derivative which inhibits P-glycoprotein, arrests cell cycle and induces apoptosis in multidrug resistance cells.
    Lopes-Rodrigues V, Oliveira A, Correia-da-Silva M, Pinto M, Lima RT, Sousa E, Vasconcelos MH.
    Bioorg Med Chem; 2017 Jan 15; 25(2):581-596. PubMed ID: 27908756
    [Abstract] [Full Text] [Related]

  • 6. SH003 reverses drug resistance by blocking signal transducer and activator of transcription 3 (STAT3) signaling in breast cancer cells.
    Seo HS, Ku JM, Lee HJ, Woo JK, Cheon C, Kim M, Jang BH, Shin YC, Ko SG.
    Biosci Rep; 2017 Dec 22; 37(6):. PubMed ID: 28864784
    [Abstract] [Full Text] [Related]

  • 7. LLY17, a novel small molecule STAT3 inhibitor induces apoptosis and suppresses cell migration and tumor growth in triple-negative breast cancer.
    Pan L, Chen X, Fu S, Yu W, Li C, Wang T, Lo HW, Lin J.
    Breast Cancer Res Treat; 2020 May 22; 181(1):31-41. PubMed ID: 32240456
    [Abstract] [Full Text] [Related]

  • 8. Discovery of oral-available resveratrol-caffeic acid based hybrids inhibiting acetylated and phosphorylated STAT3 protein.
    Li S, Zhang W, Yang Y, Ma T, Guo J, Wang S, Yu W, Kong L.
    Eur J Med Chem; 2016 Nov 29; 124():1006-1018. PubMed ID: 27783972
    [Abstract] [Full Text] [Related]

  • 9. Curcumin Derivatives Verify the Essentiality of ROS Upregulation in Tumor Suppression.
    Nakamae I, Morimoto T, Shima H, Shionyu M, Fujiki H, Yoneda-Kato N, Yokoyama T, Kanaya S, Kakiuchi K, Shirai T, Meiyanto E, Kato JY.
    Molecules; 2019 Nov 10; 24(22):. PubMed ID: 31717651
    [Abstract] [Full Text] [Related]

  • 10. Novel STAT3 phosphorylation inhibitors exhibit potent growth-suppressive activity in pancreatic and breast cancer cells.
    Lin L, Hutzen B, Zuo M, Ball S, Deangelis S, Foust E, Pandit B, Ihnat MA, Shenoy SS, Kulp S, Li PK, Li C, Fuchs J, Lin J.
    Cancer Res; 2010 Mar 15; 70(6):2445-54. PubMed ID: 20215512
    [Abstract] [Full Text] [Related]

  • 11. Rational drug design of benzothiazole-based derivatives as potent signal transducer and activator of transcription 3 (STAT3) signaling pathway inhibitors.
    Gao D, Jin N, Fu Y, Zhu Y, Wang Y, Wang T, Chen Y, Zhang M, Xiao Q, Huang M, Li Y.
    Eur J Med Chem; 2021 Apr 15; 216():113333. PubMed ID: 33689932
    [Abstract] [Full Text] [Related]

  • 12. Schisandrin A reverses doxorubicin-resistant human breast cancer cell line by the inhibition of P65 and Stat3 phosphorylation.
    Zhang ZL, Jiang QC, Wang SR.
    Breast Cancer; 2018 Mar 15; 25(2):233-242. PubMed ID: 29181822
    [Abstract] [Full Text] [Related]

  • 13. A Ferrocene Derivative Reduces Cisplatin Resistance in Breast Cancer Cells through Suppression of MDR-1 Expression and Modulation of JAK2/STAT3 Signaling Pathway.
    Noori S, Nourbakhsh M, Farzaneh S, Zarghi A.
    Anticancer Agents Med Chem; 2020 Mar 15; 20(18):2285-2292. PubMed ID: 32767949
    [Abstract] [Full Text] [Related]

  • 14. Discovery, synthesis, and evaluation of small-molecule signal transducer and activator of transcription 3 inhibitors.
    Shi ZB, Zhao D, Huang YY, Du Y, Cao XR, Gong ZN, Zhao R, Li JX.
    Chem Pharm Bull (Tokyo); 2012 Mar 15; 60(12):1574-80. PubMed ID: 23207637
    [Abstract] [Full Text] [Related]

  • 15. NO-releasing STAT3 inhibitors suppress BRAF-mutant melanoma growth.
    Kaoud TS, Mohassab AM, Hassan HA, Yan C, Van Ravenstein SX, Abdelhamid D, Dalby KN, Abdel-Aziz M.
    Eur J Med Chem; 2020 Jan 15; 186():111885. PubMed ID: 31784187
    [Abstract] [Full Text] [Related]

  • 16. Synthesis and biological evaluation of some novel triazole hybrids of curcumin mimics and their selective anticancer activity against breast and prostate cancer cell lines.
    Mandalapu D, Saini KS, Gupta S, Sharma V, Yaseen Malik M, Chaturvedi S, Bala V, Hamidullah, Thakur S, Maikhuri JP, Wahajuddin M, Konwar R, Gupta G, Sharma VL.
    Bioorg Med Chem Lett; 2016 Sep 01; 26(17):4223-32. PubMed ID: 27496212
    [Abstract] [Full Text] [Related]

  • 17. Growth-suppressive activity of raloxifene on liver cancer cells by targeting IL-6/GP130 signaling.
    Wang Y, Ma H, Zhao C, Liu T, Yan D, Jou D, Li H, Zhang C, Lü J, Li C, Lin J, Li S, Lin L.
    Oncotarget; 2017 May 16; 8(20):33683-33693. PubMed ID: 28430601
    [Abstract] [Full Text] [Related]

  • 18. Discovery of fluorescent coumarin-benzo[b]thiophene 1, 1-dioxide conjugates as mitochondria-targeting antitumor STAT3 inhibitors.
    Cai G, Yu W, Song D, Zhang W, Guo J, Zhu J, Ren Y, Kong L.
    Eur J Med Chem; 2019 Jul 15; 174():236-251. PubMed ID: 31048139
    [Abstract] [Full Text] [Related]

  • 19. Design, synthesis and biological evaluation of novel potent STAT3 inhibitors based on BBI608 for cancer therapy.
    Feng KR, Wang F, Shi XW, Tan YX, Zhao JY, Zhang JW, Li QH, Lin GQ, Gao D, Tian P.
    Eur J Med Chem; 2020 Sep 01; 201():112428. PubMed ID: 32603980
    [Abstract] [Full Text] [Related]

  • 20. Discovery of an Orally Selective Inhibitor of Signal Transducer and Activator of Transcription 3 Using Advanced Multiple Ligand Simultaneous Docking.
    Yu W, Li C, Zhang W, Xia Y, Li S, Lin JY, Yu K, Liu M, Yang L, Luo J, Chen Y, Sun H, Kong L.
    J Med Chem; 2017 Apr 13; 60(7):2718-2731. PubMed ID: 28245116
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.